Stocktoria
Cronos Group Inc. CRON
Cronos Group Inc. (CRON) earns a Piotroski F-score of 6/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $193.4M at a -4.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.93 — grey zone (between the usual thresholds). A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CRON | Cronos Group Inc. | 6/9 | — | — | +19.5% |
| BTMD | biote Corp. | 5/9 | 0.92 | 2.5 | -2.5% |
| GLAS | Glass House Brands Inc. | 3/9 | -1.45 | — | -9.4% |
| MRMD | MARIMED INC. | 4/9 | -1.76 | — | +1.3% |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | 5/9 | 3.07 | — | +14.1% |
| NAGE | Niagen Bioscience, Inc. | 5/9 | 3.42 | 15.7 | +29.9% |
| JUSHF | Jushi Holdings Inc. | 3/9 | -4.96 | — | +2.1% |
About Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
FAQ
Is CRON financially healthy?
Cronos Group Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak).
Does CRON pay a dividend?
No, Cronos Group Inc. does not currently pay a dividend.
How profitable is CRON?
In FY2025, Cronos Group Inc. had a net margin of -4.9% and a return on equity of -0.8%.
What is the analyst price target for CRON?
The average Wall-Street price target for Cronos Group Inc. is $2.50, about 21.0% below the recent price, from 1 analysts (consensus: strong buy).
Is CRON a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Cronos Group Inc.: a Piotroski F-score of 6/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.